Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli

Circulation Research

Volumn 81, Issue 2, 1997, Pages 274-281

  Henninger, Dwight D ^a   Gerritsen, Mary E ^b   Neil Granger, D ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

Hypercholesterolemia; Inflammation; Leukotriene; Platelet activating factor; Tumor necrosis factor

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; LOW DENSITY LIPOPROTEIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; HYPERCHOLESTEROLEMIA; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030857878     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.2.274     Document Type: Article

References (44)

1. Fleet JC, Clinton SK, Salomon RN, Loppnow H, Libby P. Atherogenic diets enhance endotoxin-stimulated interleukin-l and tumor necrosis factor gene expression in rabbit aortae J Nutr. 1992;122:294-305.
2. Masuda J, Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate, II: tally streak conversion to fibrous plaque. Arteriosclerosis. 1990;10:178-187.
3. Masuda J, Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate, I: fatty streak formation. Arteriosclerosis. 1990;10:164-177.
4. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991;88:5252-5256.
5. Kurose I, Argenbright LW, Anderson DC, Tolley J, Miyasaka M, Granger DN. Reperfusion-induced leukocyte adhesion and vascular protein leakage in normal and hypercholesterolemic rats. Am J Physiol. In press.
6. Gauthier TW, Scalia R, Murohara T, Guo J-P, Lefer AM. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15:1652-1659.
7. Kimura M, Kurose I, Russell J, Granger DN. Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. Arterioscler Thromb Vasc Biol. In press.
8. Lefer AM, Ma X-L. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 1993;13:771-776.
9. Ku G, Thoma CA, Akeson AL, Jackson RL. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J Biol Chem. 1992;267:14183-14188.
10. Kinne N, Gimbrone MA. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994;93:907-911.
11. Henninger DD, Liao L, Kurose I, Granger DN. Nitric oxide as a modulator of leukocyte function in atherosclerosis. In: Kubes P, ed. Nitric Oxide: A Modulator of Cell-Cell Interactions in the Microcirculation. Austin, Tex: RG Landes; 1995:127-155.
12. Wejrich AS, Buerke M, Albertine KH, Lefer AM. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol. 1995;57:45-55.
13. McMurray HF, Parthasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest. 1993;92:1004-1008.
14. Terkeltaub R, Banka CL, Solan J, Santoro D, Brand K, Curtiss LK. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb. 1994;14:47-53.
15. Gimbrone MA, Cybulsky MI, Kume N, Collins T, Resnick N. Vascular endothelium: an integrator of pathophysiological stimuli in atherogenesis. Ann N Y Acad Sci. 1995;748:122-131.
16. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993;92:883-893.
17. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesterol ester transfer protein. Nature. 1993;364:73-75.
18. Plump AS, Smith JD, Hayck T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
19. Pemberton M, Anderson G, Vetvicka V, Justus DE, Ross GD. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol. 1993;150:5104-5113.
20. Takei F. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol. 1985;134:1403-1407.
21. Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lymphohemopoiesis. J Exp Med. 1991;173:599-607.
22. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursor in culture. J Cell Biol. 1991;114:557-565.
23. Henninger DD, Panes J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, Granger DN. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol. 1997;158:1825-1832.
24. Eppihimer MJ, Wolitzky B, Anderson DC. Labow MA, Granger DN. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res. 1996;79:560-569.
25. Brito BE, Romano EL, Grunfeld C. Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits. Clin Exp Immunol. 1995;101:357-361.
26. Zimmerman BJ, Holt JW, Paulson JC, Anderson DC, Miyasaka M, Tamatani T, Todd RF III, Rusche JR, Granger DN. Molecular determinants of lipid mediator induced leukocyte adherence and emigration in rat mesenteric venules. Am J Physiol. 1994;266:H847-H853.
27. Sobhani I, Hochlaf S, Denizot Y, Vissuzaine C, Rene E, Benveniste J. Lewin MMJ, Mignon M. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut. 1992;33:1220-1225.
28. Lauritsen K, Laursen LS, Bukhave K, Raske-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroentrology. 1988;95:11-17.
29. Kubes P, Ibbotson G, Russell J, Wallace JL, Granger DN. Role of platelet-activating factor in reperfusion-induced leukocyte adherence. Am J Physiol. 1990;259:G300-G305.
30. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest. 1991;87:2036-2041.
31. Granger DN, Grisham MB, Kvietys PR. Mechanisms of microvascular injury. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 3rd ed. New York, NY: Raven Press Publishers; 1994:1693-1721.
32. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988;85:2805-2809.
33. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
34. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Ohta Y, Yasue H. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am J Physiol. 1994;267:H2441-H2449.
35. Yokoyama M, Hirata K-I, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1990;168:301-308.
36. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.
37. Lehr HA, Seemüller J, Hub̈ner C, Menger MD, Messmer K. Oxidized LDL-induced leukocytc/endothelium interaction in vivo involves the receptor for platelet-activating factor. Arterioscler Thromb. 1993;13:1013-1018.
38. Cybulsky M, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
39. Wood KM, Cadogan MD, Ramshaw AL, Parums DV. The distribution of adhesion molecules in human atherosclerosis. Histopathology. 1993;22:437-444.
40. Johnson RR, McGregor L, Taylor RN, Poston RN. Increase in the adhesion molecule P-sclectin in endothelium overlying atherosclerotic plaques: coexpression with intercellular adhesion molecule-1. Am J Pathol. 1994;144:952-961.
41. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, Smith CW, Haberland ME, Fogelman AM, Berliner JA, Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb. 1994;14:427-433.
42. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest. 1993;92:471-478.
43. Lehr H-A, Kröber M, Hübner C, Vajkoczy P, Menger MD, Nolte D, Kohlschütter A, Messmer K. Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Lab Invest. 1993;68:388-395.
44. Kurtel H, Liao L, Grisham MB, Tso P, Aw TY, Anderson DC, Miyasaka M, Granger DN. Mechanisms of oxidized chylomicron-induced leukocyte-endothelial cell adhesion. Am J Physiol. 1995;268:H2175-H2182.